Sanofi ADR Clears Key Benchmark, Hitting 80-Plus RS Rating
Investor's Business Daily rates stocks from 1 to 99 based on market leadership. High RS Rating above 80 in early stages often leads to top performance. Sanofi ADR shows positive growth in earnings and sales, ranking 4th in the Medical-Ethical Drugs industry.